Comparison of Two Different Doses of Bleomycin in Electrochemotherapy Protocols for Feline Cutaneous Squamous Cell Carcinoma Nonsegregated from Ultraviolet Light Exposure

Overview

Journal Sci Rep

Specialty Science

Date 2020 Oct 28

PMID 33110198

Citations 7

Authors

Denner S Dos Anjos

Oscar R Sierra

Enrico P Spugnini

Andrigo B de Nardi

Carlos E Fonseca-Alves

Affiliations

Soon will be listed here.

Abstract

Cutaneous squamous cell carcinoma (cSCC) is one of the most common skin tumors in cats due to chronic exposure to ultraviolet light. Local treatments such as electrochemotherapy (ECT) promote disease control or even complete remission. We hypothesize that cats could benefit from treatments using bleomycin at reduced dosages. A prospective nonrandomized single-blind study evaluated the clinical parameters, site lesion, staging, disease-free interval (DFI) and survival time by comparing the standard dose of bleomycin (15,000 UI/m) (n = 22) with a reduced dose (10,000 UI/m) (n = 34) in cats with cSCC that underwent ECT as the sole treatment modality. No statistically significant difference in DFI or overall survival was observed between the 2 groups. A higher DFI was found in cats with a small tumor size (less than 0.33 cm) compared with that for cats with a large tumor size (P = 0.045). Furthermore, a reduced overall survival time for cats with a higher stage in the standard group SG (T3 and T4) (P = 0.004) was observed when compared to that for cats with a lower stage (T1 and T2). In conclusion, ECT using both doses of bleomycin may achieve the same response rate in terms of the overall response, DFI, and overall survival.

Citing Articles

Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs.

Bromfield J, Zaugg J, Straw R, Cathie J, Krueger A, Sinha D mSphere. 2024; 9(4):e0055523.

PMID: 38530017 PMC: 11036808. DOI: 10.1128/msphere.00555-23.

Electroporation in Translational Medicine: From Veterinary Experience to Human Oncology.

Spugnini E, Condello M, Crispi S, Baldi A Cancers (Basel). 2024; 16(5).

PMID: 38473422 PMC: 10930471. DOI: 10.3390/cancers16051067.

Electrochemotherapy for the treatment of basal cell tumours of the nasal planum in three cats.

Salmoral A, Penzo C, Baines S JFMS Open Rep. 2024; 10(1):20551169231213499.

PMID: 38322251 PMC: 10846178. DOI: 10.1177/20551169231213499.

Electrochemotherapy using thin-needle electrode improves recovery in feline nasal planum squamous cell carcinoma - a translational model.

Tellado M, Michinski S, Impellizeri J, Marshall G, Signori E, Maglietti F Cancer Drug Resist. 2022; 5(3):595-611.

PMID: 36176753 PMC: 9511808. DOI: 10.20517/cdr.2022.24.

VEGF Expression, Cellular Infiltration, and Intratumoral Collagen Levels after Electroporation-Based Treatment of Dogs with Cutaneous Squamous Cell Carcinoma.

Dos Anjos D, Bueno C, Mattos-Junior E, De Nardi A, Fonseca-Alves C Life (Basel). 2021; 11(12).

PMID: 34947852 PMC: 8708059. DOI: 10.3390/life11121321.

References

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

Spugnini E, Vincenzi B, Amadio B, Baldi A . Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases. Open Vet J. 2019; 9(1):88-93. PMC: 6500853. DOI: 10.4314/ovj.v9i1.15. View

Campana L, Clover A, Valpione S, Quaglino P, Gehl J, Kunte C . Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review. Radiol Oncol. 2016; 50(1):1-13. PMC: 4825335. DOI: 10.1515/raon-2016-0006. View

Cemazar M, Sersa G, Frey W, Miklavcic D, Teissie J . Recommendations and requirements for reporting on applications of electric pulse delivery for electroporation of biological samples. Bioelectrochemistry. 2018; 122:69-76. DOI: 10.1016/j.bioelechem.2018.03.005. View

Cemazar M, Sersa G . Recent Advances in Electrochemotherapy. Bioelectricity. 2021; 1(4):204-213. PMC: 8370294. DOI: 10.1089/bioe.2019.0028. View

Groselj A, Bosnjak M, Strojan P, Krzan M, Cemazar M, Sersa G . Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results. Head Neck. 2017; 40(1):120-125. DOI: 10.1002/hed.24991. View

Martinez-Ruzafa I, Dominguez P, Dervisis N, Sarbu L, Newman R, Cadile C . Tolerability of gemcitabine and carboplatin doublet therapy in cats with carcinomas. J Vet Intern Med. 2009; 23(3):570-7. DOI: 10.1111/j.1939-1676.2009.0279.x. View

Mali B, Miklavcic D, Campana L, Cemazar M, Sersa G, Snoj M . Tumor size and effectiveness of electrochemotherapy. Radiol Oncol. 2013; 47(1):32-41. PMC: 3573832. DOI: 10.2478/raon-2013-0002. View

Spugnini E, Fais S, Azzarito T, Baldi A . Novel Instruments for the Implementation of Electrochemotherapy Protocols: From Bench Side to Veterinary Clinic. J Cell Physiol. 2016; 232(3):490-495. DOI: 10.1002/jcp.25505. View

10.

Tozon N, Tratar U, Znidar K, Sersa G, Teissie J, Cemazar M . Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats. J Vis Exp. 2016; (116). PMC: 5092241. DOI: 10.3791/54760. View

11.

David E, Blanchard F, Heymann M, De Pinieux G, Gouin F, Redini F . The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. Sarcoma. 2011; 2011:932451. PMC: 3103994. DOI: 10.1155/2011/932451. View

12.

Spugnini E, Vincenzi B, Citro G, Tonini G, Dotsinsky I, Mudrov N . Electrochemotherapy for the treatment of squamous cell carcinoma in cats: a preliminary report. Vet J. 2007; 179(1):117-20. DOI: 10.1016/j.tvjl.2007.08.011. View

13.

Spugnini E, Fanciulli M, Citro G, Baldi A . Preclinical models in electrochemotherapy: the role of veterinary patients. Future Oncol. 2012; 8(7):829-37. DOI: 10.2217/fon.12.64. View

14.

Tozon N, Pavlin D, Sersa G, Dolinsek T, Cemazar M . Electrochemotherapy with intravenous bleomycin injection: an observational study in superficial squamous cell carcinoma in cats. J Feline Med Surg. 2013; 16(4):291-9. PMC: 11383118. DOI: 10.1177/1098612X13507071. View

15.

Spugnini E, Pizzuto M, Filipponi M, Romani L, Vincenzi B, Menicagli F . Electroporation Enhances Bleomycin Efficacy in Cats with Periocular Carcinoma and Advanced Squamous Cell Carcinoma of the Head. J Vet Intern Med. 2015; 29(5):1368-75. PMC: 4858043. DOI: 10.1111/jvim.13586. View

16.

Spugnini E, Vincenzi B, Carocci F, Bonichi C, Menicagli F, Baldi A . Combination of bleomycin and cisplatin as adjuvant electrochemotherapy protocol for the treatment of incompletely excised feline injection-site sarcomas: A retrospective study. Open Vet J. 2020; 10(3):267-271. PMC: 7703611. DOI: 10.4314/ovj.v10i3.4. View

17.

Spugnini E, Vincenzi B, Citro G, Santini D, Dotsinsky I, Mudrov N . Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas. In Vivo. 2007; 21(5):819-22. View

18.

Murphy S . Cutaneous squamous cell carcinoma in the cat: current understanding and treatment approaches. J Feline Med Surg. 2013; 15(5):401-7. PMC: 10816592. DOI: 10.1177/1098612X13483238. View

19.

Spugnini E, Melillo A, Quagliuolo L, Boccellino M, Vincenzi B, Pasquali P . Definition of novel electrochemotherapy parameters and validation of their in vitro and in vivo effectiveness. J Cell Physiol. 2014; 229(9):1177-81. DOI: 10.1002/jcp.24548. View

20.

Cunha S, Carvalho L, Canary P, Reisner M, Corgozinho K, Souza H . Radiation therapy for feline cutaneous squamous cell carcinoma using a hypofractionated protocol. J Feline Med Surg. 2009; 12(4):306-13. PMC: 11135594. DOI: 10.1016/j.jfms.2009.10.005. View